Trial intelligence / Profile preview

Celecoxib for the Prevention of Sunburn Effects in Healthy Volunteers

NCT02099136Phase 2Completed

Sponsor
National Cancer Institute
Start
Sep 1999
Primary completion
Sep 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of celecoxib oral solution in sunburn, sponsored by National Cancer Institute. Started Sep 1999; status: completed.

02

Drugs

celecoxib oral solution
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02099136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02099136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call